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Abstract 
Previous studies have shown that the exposure to an open elevated plus maze (oEPM, 
an EPM with all four open arms) elicits fear/anxiety-related responses in laboratory 
rodents. However, very little is known about the underlying neural substrates of these 
defensive behaviors. Accordingly, the present study investigated the effects of chemical 
inactivation of the amygdala [through local injection of cobalt chloride (CoCl2: a 
nonspecific synaptic blocker)] on the behavior of oEPM-exposed mice. In a second 
experiment, the pattern of activation of the basolateral (BLA) and central (CeA) nuclei 
of the amygdala was assessed through quantification of Fos protein expression in mice 
subjected to one of several behavioral manipulations. To avoid the confound of acute 
handling stress, 4 independent groups of mice were habituated daily for 10 days to an 
enclosed EPM (eEPM) and, on day 11 prior to immunohistochemistry, were either 
taken directly from their home cage (control) or individually exposed for 10 minutes to 
a new clean holding cage (novelty), an eEPM, or the oEPM. An additional group of 
mice (maze-naïve) was not subjected to either the habituation or exposure phase but 
were simply chosen at random from their home cages to undergo an identical 
immunohistochemistry procedure. Results showed that amygdala inactivation produced 
an anxiolytic-like profile comprising reductions in time spent in the proximal portions 
of the open arms and total stretched attend postures (SAP) as well as increases in time 
spent in the distal portions of the open arms and total head-dipping. Moreover, Fos-
positive labeled cells were bilaterally increased in the amygdaloid complex, particularly 
in the BLA, of oEPM-exposed animals compared to all other groups. These results 
suggest that the amygdala (in particular, its BLA nucleus) plays a key role in the 
modulation of defensive behaviors in oEPM-exposed mice. 
 
Key words: Open elevated plus maze; amygdala; immunohistochemistry; cobalt 
chloride; defensive behavior; mice
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1. Introduction 
Animals exhibit various neurovegetative (e.g., increased blood pressure, 
defecation) and behavioral (e.g., freezing, flight) responses when confronted with innate 
or learned danger stimuli. These defensive responses can be detected through animal 
tests for anxiety. For instance, rodents exposed to predators [1, 2], novelty [3, 4] or open 
environments [5, 6, 7, 8, 9] display a range of defensive reactions (e.g., escape, 
avoidance, freezing and antinociception).  
The open elevated plus maze (oEPM) is a type of highly aversive environment 
that has been used to study the neurobiology of fear-induced antinociception [8, 10, 11, 
12] and defensive behaviors [9]. This new paradigm is similar to that described by 
Lister (1987) [6], except that it comprises four open arms, instead of two open and two 
closed arms. Exposure of mice to the oEPM enhances plasma corticosterone titers [8] 
and elicits defensive behaviors such as stretched attend postures, flatback approach, and 
head dipping [9]. Furthermore, systemic injection of alprazolam, a potent 
benzodiazepine [13], attenuates defensive behavior in mice exposed to this test, 
suggesting that the procedure is sensitive to anxiolytic/panicolytic drugs [9]. At present, 
very little is known about the neural substrates that modulate the defensive behavior of 
animals exposed to the oEPM. However, it has been reported that chemical lesions of 
dorsal or ventro-lateral portions of the periaqueductal grey matter (dPAG or vlPAG), 
components of midbrain defense circuitry [14], do not change oEPM-induced 
antinociception [12, 15], a type of fear/anxiety-induced pain inhibition.  
Cellular and functional studies have repeatedly demonstrated that the 
amygdaloid complex plays a crucial role in the modulation of fear and anxiety 
behaviors. Previous findings have shown that this forebrain area receives and processes 
aversive stimuli [e.g., 16, 17]. The amygdala comprises a set of nuclei, with complex 
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inter- and intra-nuclear connections and which are subdivided into three main groups: 
the basolateral, corticomedial and centromedial groups [review: 17]. Previous studies 
have shown that these amygdaloid subnuclei are differentially involved in the 
modulation of defensive behaviors [16, 18, 19]. For example, electrolytic lesion 
specifically of the central nucleus (CeA) and basolateral nucleus (BLA) of the amygdala 
attenuate fear-related responses [review: 17]. Furthermore, Tanimoto et al. [19] 
demonstrated that bilateral chemical lesions of the BLA or CeA decrease conditioned 
place aversion in rats induced by plantar injection of formalin. In addition, cellular 
imaging of immediate early genes (IEG), such as c-fos, zif268, and arc, has also been 
used to map the neuronal substrate involved in behavior [20-23]. The protein Fos has 
been the most commonly used IEG marker of neuronal activity in behavioral research, 
including studies on fear and anxiety [24].  For instance, increased Fos expression has 
been identified in the amygdala of animals exposed to a conventional EPM [25-29]. 
Together, this body of evidence suggests that the amygdala might play a role in the 
modulation of defensive reactions displayed by mice during the exposure to the oEPM.  
Although the amygdala is a bilateral structure, previous studies have revealed a 
degree of functional lateralization in the modulation of emotional responses in animals 
[30] and humans [31]. For example, Baker and Kim (2004) [30] found that the right 
amygdala exerts a strong role in the control of contextual fear conditioning in rats. 
Briefly, electrolytic lesions of the right (but not the left) amygdala decreased freezing 
behavior in rats exposed to the fear-associated context. In contrast, Tran and 
Greenwood-Van Meerveld (2012) [32] showed a lack of hemispheric lateralization of 
the CeA in the control of corticoid-mediated anxiety-like behavior assessed in rats 
exposed to the EPM. These findings suggest the potential importance of hemispheric 
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lateralization in the role of the amygdala in the modulation of defensive behavior of 
animals exposed to threatening situations, such as the oEPM.  
Here, we investigated (i) the effects of chemical inactivation (through local 
injection of cobalt chloride (CoCl2), an nonspecific synaptic blocker [33]) of the 
amygdala on the behavior of mice exposed to the oEPM; and (ii) the pattern of neuronal 
activation of the left and right amygdaloid complex and of the BLA and CeA subnuclei 
through quantification of Fos protein expression in mice exposed to the oEPM versus a 
number of important control conditions, including an enclosed EPM (eEPM, an EPM 
with four enclosed arms; control situation) and a non-maze novel environment (new 
cage). Basal Fos protein expression was also recorded in maze-naïve mice. This study 
therefore sought to clarify the role of the amygdala in the modulation of the defensive 
behavior of animals exposed to the oEPM and to further explore this new paradigm as a 
potential tool for research on the neurobiology of fear/anxiety.  
 
2. Materials and methods  
2.1. Subjects 
Subjects were adult male Swiss mice (Univ. Estadual Paulista ± UNESP, SP, 
Brazil) weighing 25±35 g at testing. They were housed in groups of 5 per cage 
(33×15×13 cm) and maintained under a normal 12 h light cycle (lights on at 7 a.m.) in a 
temperature (23 ± 1° C) controlled environment. Food and water were freely available, 
except during the brief test periods. All mice were experimentally naive, and 
experimental sessions were performed during the light phase of the cycle (09.00h-
16.00h). The experimental protocols were approved by the Research Ethics Committee 
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of the School of Pharmaceutical Sciences of the Universidade Estadual Paulista ± 
UNESP (CEUA number 14/2014).  
 
2.2. Drug 
Cobalt chloride (CoCl2; Sigma-Aldrich, Brazil) was dissolved in 0.9% 
physiological saline solution which alone served as control solution. The dose of 1.0 
mM of CoCl2 was based on previous studies [34, 35], and the total volume of injection 
within the amygdala was 0.1 µL.  
 
2.3. Surgery and microinjection 
Mice were bilaterally implanted with 7-mm stainless-steel guide cannulae (26-
gauge; Insight Equipamentos Científicos Ltda) under ketamine and xylazine anaesthesia 
(100 mg/kg and 10 mg/kg i.p.). Guide cannulae, targeted 1.0 mm dorsal to the 
DP\JGDODZHUHIL[HGWRWKHVNXOOXVLQJGHQWDODFU\OLFDQGMHZHOHU¶VVFUHZV6WHUHRWD[LF
coordinates for the amygdala, based on Paxinos and Franklin (2001) [36] and a previous 
study in our laboratory [37], were 1.1 mm posterior to bregma, 3.1 mm lateral to the 
midline and 3.7 mm ventral to the skull surface. A dummy cannula (33-gauge stainless-
steel wire; Fishtex Indústria e Comércio de Plásticos Ltda), inserted into each guide-
cannula at the time of surgery, served to reduce the incidence of occlusion. At the end of 
the stereotaxic surgery, each mouse received an intramuscular injection of penicillin-G 
benzathine (Pentabiotic, 56.7 mg/kg in a 0.1 mL volume; Fort Dodge, Campinas, SP, 
Brazil) and a subcutaneous injection of the anti-inflammatory analgesic Banamine (3.5 
mg/kg flunixin meglumine, Intervet Schering±Plough, Rio de Janeiro, RJ, Brazil, in a 
volume of 0.3 mL). 
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Five days after following surgery, solutions were injected into the amygdala by 
microinjection units (33-gauge stainless steel cannulae; Insight Equipamentos 
Científicos Ltda), which extended 1.0 mm beyond the tip of each guide cannula. Each 
microinjection unit was attached to a 2 µL Hamilton microsyringe via polyethylene 
tubing (PE-10), and administration was controlled by the experimenter at a rate of 0.1 
µL (volume injected) over a period of approximately 20 s. The microinjection procedure 
consisted of gently restraining the animal, removing the dummy cannulae, inserting the 
injection units, infusing the solution, and keeping the injection units in situ for a further 
60 s. Confirmation of successful infusion was obtained by monitoring the movement of 
a small air bubble in the PE-10 tubing. 
 
2.4. Apparatus 
The open elevated plus-maze (oEPM) is closely similar to the standard EPM 
(EPM) described by Lister (1987) [6] except that it has four open (30 × 5 × 0.25 cm) 
arms, raised 38.5 cm above floor level on a wooden pedestal. Each arm of the oEPM 
was divided into two sections, which were designated as proximal (10 x 5 cm) and 
distal [medial and end of the arms (20 x 5 cm)] portions relative to the central square 
(5×5 cm) [for details, see 9]. In Experiment 2, amygdaloid c-Fos activation in response 
to oEPM exposure was contrasted with exposure to an enclosed elevated plus-maze 
(eEPM; four enlcosed arms; 30 x 5 x 15cm; raised 38.5 cm above floor level) and an 
unfamiliar, clean home cage (33 x 15 x 13 cm).  
 
2.5. Procedure 
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All behavioral tests were conducted during the light phase of the light/dark 
cycle, under the illumination of a 100-W light bulb (50 lux on the floor of the 
apparatus).  
 
2.5.1. Experiment 1 
2.5.1.1. Effects of amygdala inactivation on the behavior of mice exposed to the oEPM  
In order to investigate the role of the amygdala in the modulation of defensive 
behavior of mice exposed to the oEPM, each mouse received a bilateral intra-amygdala 
injection of saline or CoCl2 (1.0 mM) and, after 10 minutes, was individually placed on 
the central square (always facing the same arm) and allowed to explore the oEPM freely 
for 10 minutes. Between each test, the apparatus was cleaned with ethanol 20% and 
dried clothes. All sessions were recorded by a vertically mounted camera linked to a 
monitor and DVD recorder.  
 
2.5.1.2. Behavioral analysis 
Test DVDs were scored blind by a highly trained observer (intrarater reliability 
XVLQJWKHVRIWZDUH³;-plo-UDW´GHYHORSHGE\'U0RUDWR¶V*URXSDWWKH
Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto, University of São Paulo. 
The behavioral parameters comprised both spatiotemporal and ethological measures. 
Spatiotemporal measures were the frequency of entries and time spent on the central 
platform and in each section (proximal, distal) of the arms. Ethological measures 
comprised total stretched attend postures (SAP; exploratory posture in which the body 
is stretched forward then retracted to the original position without any forward 
locomotion), total flat back approach (s) (FBA; time spent slowly moving forward with 
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the body stretched), and total head-dips (HD; an exploratory behavior in which the 
animal scans over the sides of the maze towards the floor) [9, 38-40].  
 
2.5.1.3. Histology 
At the end of testing, all animals received an infusion of 1% Evans blue 
(according to the microinjection procedure described above, on section 2.3) prior to 
anesthetic overdose. Their brains were removed, coronal sections cut using a cryostat 
microtome (Leica CM 1850), and injection sites histologically verified through 
reference to the atlas of Paxinos and Franklin [36]. Slices were stained by the cresyl-
violet technique. Data from animals with injection sites outside the amygdala were 
excluded from the study.   
 
2.5.2. Experiment 2  
2.5.2.1. Amygdaloid Fos activation in response to the oEPM 
This experiment examined the pattern of amygdala activation in mice exposed 
either to the oEPM or a number of control conditions. The procedure for 4 groups of 
mice involved habituation and exposure phases. The habituation phase was used to 
avoid confounds arising from acute handling stress. During habituation, each subject 
was exposed for a 10-min period daily over 10 consecutive days to an eEPM. In 
contrast to the standard EPM, in which the two open arms are sources of threat, the 
totally enclosed EPM was selected as a control condition in order to create a relatively 
safe environment. During the exposure phase (Day 11), subjects were either taken from 
their home cage (control group) or individually exposed to the eEPM, a novel 
environment (unfamiliar clean home cage) or oEPM for 10 minutes. Maze-naïve 
animals were randomly chosen from their home cages to undergo the same 
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immunohistochemistry protocol. Ninety minutes after the exposure to the novel home 
cage, eEPM or oEPM, animals were deeply anesthetized, perfused transcardially with 
PBS followed by a solution of 4% paraformaldehyde and brains removed for 
immunohistochemistry. Control and maze-naïve mice were also deeply anesthetized and 
perfused immediately after they had been removed from their home cages.   
 
2.5.2.2. Immunohistochemisty 
Brains were removed and left overnight in a solution of 30% sucrose in 0.1M 
phosphate buffer saline (PBS) at 4ºC. The brains were then frozen and three series of 
35µm sections were cut with a cryostat microtome (Leica CM 1850) and one of the 
series was processed for immunohistochemistry. Slices was washed three times (10 min. 
each) in PBS at room temperature on a shaker and was placed into blocking buffer 
(normal goat serum 3% and Triton X-100 0.25% in PBS) for one hour at room 
temperature. After blocking, slices were incubated overnight with an anti-Fos antiserum 
raised in rabbit (Cell Signaling Technology, Danvers, MA, USA) at a dilution of 
1:2,000. Slices were again washed three times and incubated in a solution of 
biotinylated goat anti-rabbit IgG (Vector Laboratories, Burlingame, CA, USA) at 
dilution of 1:400 for 2 hours and then placed in the mixed avidin±biotin horseradish 
peroxidase (HRP) complex solution (ABC Elite Kit; Vector Laboratories) for 1 hour. 
Immunoreactivity for Fos was revealed by the addition of the chromogen 
diaminobenzidin (DAB, 0.02%, Sigma-Aldrich, Brazil), and hydrogen peroxide 
(0.04%) and was visualized as a brown insoluble reaction product inside neuronal 
nucleus after 8 minutes. The reaction was stopped by washing in PBS. Sections were 
mounted on gelatin-coated slides, and then dehydrated and coverslipped with Permount 
(Sigma-Aldrich, Brazil). The number of Fos immunoreactive neurons in the BLA and 
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CeA of each hemisphere were counted using an optic microscopic (Zeiss Axioskop 2) 
coupled with a camera and the Axio Vision Rel. Zeiss software was used to quantify 
Fos-positive labeling. 
 
2.5.3. Statistical analysis 
All data were initially subjected to Levene´s test for homogeneity of variance. 
Data from the two independent treatment groups in Experiment 1 were subjected to 
6WXGHQW¶Vt-tests. Data from Experiment 2 were subjected to a three-factor independent 
analysis of variance (ANOVA), [factor 1 (sub nuclei); factor 2 (condition); factor 3 
(hemisphere)]. Where indicated by a significant ANOVA, data were further analyzed by 
%RQIHUURQL¶V muOWLSOHUDQJHWHVW,QDOOFDVHVS05 was required for significance. 
 
Results 
3.1. Experiment 1 
 3.1.1. Histology  
Figure 1 shows a schematic representation of a brain section based on the 
Paxinos and Franklin Atlas (2001) [36], indicating microinfusion sites into the 
amygdala (left), and a photomicrograph of a coronal section of a representative subject, 
showing an injection site in the amygdala of the mouse (right). Histology confirmed that 
82% of the microinfusion sites were in the basolateral (lateral + basal nuclei) nucleus 
(see Fig. 1) and 8% were in the central amygdala. 
 
Figure 1 about here 
 
3.1.2. Amygdala inactivation in the oEPM 
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Figure 2 shows the effects of intra-amygdaloid injection of CoCl2 on the 
behavioral profile of mice exposed to the oEPM. Student's t-tests revealed that 
amygdala inactivation decreased time spent in the proximal portions of the open arms 
[t(17) = 2.97; p<0.05] and total SAP [t(17) = 2.17; p<0.05] while increasing time spent in 
the distal portions of the open arms [t(17) = -2.60; p<0.05] and total head-dipping [t(17) = -
3.06; p<0.05]. Importantly, no other behavioral parameter was significantly changed by 
intra-amygdala injection of CoCl2 in mice exposed to the oEPM.  
 
Figure 2 about here 
 
 
 
3.2. Experiment 2 
3.2.1. Immunohistochemistry 
 Fig. 3A shows a coronal brain slice of a representative subject exposed to the 
oEPM indicating, on the left, a rectangle showing the amygdaloid complex and, on the 
right, the basolateral (BLA) and central (CeA) nuclei in which the Fos-labeled cells 
were particularly increased. Fig. 3B shows the number of Fos-labeled cells in the CeA 
and BLA of both hemispheres in mice exposed to the five different test conditions 
(maze-naïve, home cage control, and novelty-, oEPM- or eEPM-exposed). Except for 
the hemisphere factor which was non-significant (F1,56 = 1.09, NS), three-way ANOVA 
yielded significance (p<0.05) for sub nuclei (F1,56=15.97) and condition (F4,56=41.67), 
as well as all interactions; nuclei × hemisphere (F1,56=4.12); nuclei × condition 
(F4,56=7.36); condition × hemisphere (F4,56=2.67); nuclei × hemisphere × condition 
(F4,56=4.88). Bonferroni¶V PXOWLSOH UDQJH WHVW UHYHDOHG DQ LQFUHDVHG QXPEHU RI Fos-
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positive cells in the BLA of both hemispheres in oEPM-exposed animals. More 
specifically, oEPM-exposed mice displayed a higher number of Fos-stained cells in the 
right BLA compared to all other groups (*p<0.05) and a higher number of Fos-stained 
cells in the left BLA compared to maze-naïve- and novelty-exposed mice (#p<0.05). In 
direct contrast, oEPM exposure did not significantly alter Fos expression in the CeA of 
either hemipshere when compared with maze-naïve or home cage control conditions. 
Interestingly, however, oEPM-exposed mice had a higher number of Fos-labeled cells 
in the left CeA compared to novelty-exposed mice. Moreover, both oEPM- and eEPM-
exposed mice had an increased number of Fos-stained cells in the right CeA compared 
to novelty-exposed mice ($p<0.05). Importantly, there were no hemispheric differences 
between Fos-labeled cells in the BLA or CeA of animals exposed to any condition 
(p>0.05). 
 
Figure 3 about here 
 
3. Discussion 
The results of the present study show that chemical inactivation of the amygdala 
leads to an anxiolytic-like profile in mice exposed to the oEPM, comprising reductions 
in time spent in the proximal portions of the open arms and total SAP as well as 
increases in time spent in the distal areas of the open arms and total head-dips. The 
involvement of the amygdala in the control of defensive behavior in the oEPM was 
further indicated through quantification of Fos expression in the BLA and CeA.  In 
brief, relative to virtually all other conditions, oEPM exposure markedly increased the 
number of Fos-labeled cells within the BLA of both hemispheres. In contrast, oEPM 
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(and to a lesser extent eEPM) exposure modestly increased the number of Fos-stained 
cells within the CeA when compared with the novelty condition only. 
Experiment 1 showed that amygdala inactivation through local microinjection of 
CoCl2 decreased time proximal and total SAP, and increased time distal and total head-
dipping in mice exposed to the oEPM. In this context, it is important to note that there 
was no treatment effect on total entries, confirming that the pattern of behavioral change 
seen in response to amygdaloid inactivation cannot be attributed to an effect on general 
activity levels. In a recent factor analytic study, we reported that total SAP load on a 
IDFWRULQGLFDWLQJDUHODWLRQVKLSWRGHIHQVLYHRUµFDXWLRXV¶H[SORUDWLRQRIWKHDUPVZKLOH
the independent loading of head-dipping was consistent with depth exploration [9]. 
Moreover, systemic administration of alprazolam, a highly potent anxiolytic agent [13], 
decreased SAP and increased head-dipping in mice exposed to the oEPM [9]. 
Significantly, when displayed in a conventional or standard elevated plus-maze (sEPM), 
SAP and HD behaviors have been related to risk assessment and, as such, the currently 
observed changes in these behaviors are entirely consistent with an attenuation of 
anxiety [41, 42]. These changes, together with the shift in exploration from proximal to 
distal areas of the open arms [9], strongly suggest that inactivation of the amygdala with 
local injection of CoCl2 attenuates approach-avoidance conflict. Present results also 
corroborate previous studies showing that amygdala lesions reduced the incidence of 
anxiety-related behavior in rats exposed either to the elevated T-maze [43, 44] or the 
light-dark exploration test [43, 45].  
Our analysis of the pattern of amygdaloid activation in Experiment 2 showed an 
increase in Fos-positive labeled cells only in the BLA of oEPM-exposed mice compared 
to various control conditions. It should be noted that the apparent hemispheric 
imbalance in the BLA Fos response to oEPM exposure (Figure 3B) was not statistically 
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significant. However, whereas Fos labelling in the right BLA was significantly 
increased by oEPM exposure versus all other conditions, it was only increased in the 
left BLA versus maze-naïve and novelty-exposed mice. The lack of a significant 
difference in left BLA activation versus the home cage and e-EPM conditions does not 
however diminish the role of this nucleus in responding to the oEPM.  Since the 
subjects had been thoroughly (daily for 10 days) habituated to the eEPM prior to oEPM 
exposure, the increase in Fos-positive labeled cells might have simply been due to 
environmental novelty [46] instead of the aversiveness of the oEPM. However, our 
results actually showed that exposure to a novel environment led to the opposite effect, 
i.e. it provoked a reduction in Fos-positive labeled cells in the amygdaloid complex, 
strongly suggesting that the increased Fos expression in oEPM-exposed mice was not 
simply due to novelty. It is important to highlight that the currently employed eEPM 
habituation protocol was necessary in order to minimize the potential confound of acute 
handling stress that has been reported to be crucial to reduce per se effects on the basal 
number of Fos-positive cells [29, 47]. However, habituation is stressor specific, such 
that decreased c-fos response to a familiar stressor, does not prevent induction of this 
gene by a novel stressor [48]. Taken together, it is likely that the increase in Fos-labeled 
cells within the amygdaloid nuclei is mainly due to the aversiveness of the oEPM. In 
support of this interpretation, (a) the results of Experiment 1 showed that amygdala 
inactivation induces an anti-aversive effect in oEPM-exposed mice, (b) the results of 
Experiment 2 demonstrated that while novelty per se tended to reduce overall Fos 
expression in the amygdala, it did not significantly alter the number of Fos 
immiunoreactive cells in either the BLA or CeA, and (c) exposure to the oEPM elicits a 
stronger plasma corticosterone response than exposure to the eEPM [8].   
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Present results also show that the magnitude of Fos activation in BLA is 
distinctly higher (mainly in the right and borderline in the left) in animals exposed to the 
oEPM when compared to the response of the CeA to the same condition. It is relevant to 
highlight that the main input nucleus of the amygdala is the BLA, which receives a 
broad range of sensory input (olfactory, auditory, somatosensory) not only from the 
thalamus but also the prefrontal cortex which influences decision-making and 
behavioral control through executive outcomes [16, 49]. The CeA, in turn, sends 
outputs to areas that coordinate defensive behaviors through forebrain and brainstem 
connections [16, 49]. While oEPM exposure induced increased Fos activation in both 
left and right BLA compared to controls, the fact that this was not seen in response to 
the eEPM suggests that the more aversive a situation the greater the activation of these 
amygdaloid nuclei. This interpretation is consistent with previous studies showing 
higher plasma corticosterone levels, a biological marker of stress [50, 51], in oEPM-
exposed mice compared to eEPM-exposed mice [8]. The prominent BLA Fos 
expression suggests that this nucleus is particularly important in the modulation of 
defensive behavior induced by oEPM exposure, a hypothesis supported by previous 
findings in rats that exposure to aversive environments (e.g., open field) does not lead to 
activation of the CeA [16, 46] whereas exposure to a conventional EPM results in 
elevated c-Fos expression within the BLA [review: 16]. Taken together, our findings 
suggest that the aversive experience triggered by oEPM exposure is mostly processed in 
the BLA, a nucleus closely related to the processing of aversive input [16, 17]. This 
functional neuroanatomy may in turn relate to the relative inescapability of the threat 
posed by the oEPM and hence greater recruitment of defensive neurocircuitry [52]. 
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Although the amygdaloid complex has long been implicated in the neurobiology 
of fear and anxiety [review: 18], the underlying mechanisms of these emotional states 
remain to be fully elucidated. For instance, the medial amygdala (MeA) is implicated in 
the modulation of defensive reactions, since Fos-stained cells in the MeA appear to be 
related to the emotional novelty of the experimental situation [16].   
Furthermore, MeA seems particularly responsive to predator stimuli (e.g. odor) and to 
coordinate appropriate executive behavior through outputs to the periaqueductal gray 
[53]. As already noted, the BLA receives and processes sensory information from 
cortical and thalamic structures, and then transmits to the CeA which, in turn, projects 
to hypothalamic, midbrain and brainstem effector mechanisms. The BLA also projects 
directly to the ventral hippocampus (vHIP) and medial prefrontal cortex (mPFC) 
leading to the exhibition of defensive responses [16, 17, 54]. In addition to reciprocal 
connections with many regions of the neuraxis, the amygdala displays considerable 
intra- and inter-nucleus connectivity [16]. Importantly, the functions of these neuronal 
circuits are determined by their target-specific and/or cell-specific connections. In this 
context, cell-specific connections within the amygdaloid complex shows that while 
activation of BLA cells that project to the CeA results in anxiolysis, activation of BLA 
cells that project to the ventral hippocampus induces anxiogenesis [16, 17, 54, 55]. 
Regarding the BLA-CeA circuitry, clear evidence for an anxiolytic effect was obtained 
in an optogenetic study [56], corroborating a previous report based on a fear-
conditioning paradigm [57]. This points to a functional heterogeneity at the level of 
BLA cell types or projections suggesting that unconditional paradigms, such as oEPM 
exposure, might activate the BLA-vHIP, rather than the BLA-CeA, projection. In this 
context, since BLA-vHIP circuitry was previously reported to be anxiogenic [55], while 
present results show that amygdala inactivation promoted anxiolytic-like effects in mice 
18 
 
exposed to oEPM, we tentatively suggest that this very particular aversive experience 
may activate the BLA-ventral hippocampal pathway. 
In conclusion, our results show that the amygdaloid complex, particularly its 
basolateral nucleus, plays a significant role in the modulation of defensive behaviors in 
oEPM-exposed mice.  Further studies are needed to clarify whether other limbic areas 
(e.g., medial prefrontal cortex and ventral hippocampus) also play a role in the 
modulation of defensive behaviors induced by this type of aversive environment.  
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Figure legends 
Figure 1. Schematic diagram (left) and a photomicrograph (right) of a representative 
microinfusion site within the amygdala. Section corresponds to 1.10 mm anterior to 
bregma (Paxinos and Franklin, 2001).  
 
Figure 2. Effects of amygdala inactivation on (A) time spent on the central platform, 
proximal and distal areas of the open arms, (B) total frequency of SAP, (C) total arm 
entries, (D) total time in flatback approach (s) and (E) total frequency of head-dips. Data 
are presented as mean ± S.E.M. n = 11 vehicle group; n = 8 CoCl2 group. * P < 0.05 vs. 
vehicle group. 
 
Figure 3. (A) Representative photomicrograph of the amygdaloid complex showing 
(left) Fos-positive labeled cells and, more specifically, basolateral (BLA) and central 
(CeA) nuclei of the amygdala (right); (B) Number of Fos-positive labeled cells per mm2 
in both hemispheres of the BLA and CeA nuclei of maze-naïve (n=9); home cage 
control group (n=7); novelty-exposed (n=8); eEPM-exposed (n=9); and oEPM-exposed 
(n=8) mice. Data are presented as mean ± S.E.M. *p<0.05 versus all groups; #p<0.05 
versus maze-naïve- and novelty-exposed mice in the left BLA; $p<0.05. 
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Highlights 
Exposure of mice to the open elevated plus maze (oEPM) elicits defensive behaviors 
Inactivation of the amygdala complex leads to anxiolytic effects in oEPM-exposed mice  
oEPM exposure increases Fos labeled cells in the amygdala  
Basolateral amygdala (BLA) shows more Fos-positive cells than central amygdala 
(CeA) 
BLA plays a role in the modulation of defensive behaviors in mice exposed to the 
oEPM 
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